Binding patterns of rotavirus genotypes P[4], P[6], and P[8] in China with histo-blood group antigens

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Ma, Xin ^a,b   Li, Dan Di ^b   Sun, Xiao Man ^b   Guo, Yan Qing ^b   Xiang, Jing Yao ^b   Wang, Wei Huan ^c   Zhang, Li Xia ^a   Gu, Qing Jiu ^a   Duan, Zhao Jun ^b  

^a China Railway Construction   (China)

^b National Institute for Viral Disease Control and Prevention   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; HISTOBLOOD GROUP ANTIGEN; OLIGOSACCHARIDE; PROTEIN VP8; UNCLASSIFIED DRUG; VIRUS PROTEIN; NS35 PROTEIN, ROTAVIRUS; PROTEIN BINDING; RNA BINDING PROTEIN; VIRAL PROTEIN; VIRUS ANTIGEN;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BLOOD GROUP ABO SYSTEM; CHINA; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; NONHUMAN; NORMAL HUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; REACTION ANALYSIS; ROTAVIRUS; SALIVA ANALYSIS; ADULT; ANIMAL; BLOOD; CHILD; GASTROENTERITIS; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; RABBIT; ROTAVIRUS INFECTION; SALIVA; VIROLOGY;

ADULT; ANIMALS; ANTIGENS, VIRAL; BLOOD GROUP ANTIGENS; CHILD; FEMALE; GASTROENTERITIS; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RABBITS; RNA-BINDING PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SALIVA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84942857144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134584     Document Type: Article

References (32)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12 (2):136-41. doi: 10.1016/S1473-3099(11)70253-5 PMID: 22030330
2. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis.2003; 9(5):565-72. PMID: 12737740
3. Araujo EC, Clemens SA, Oliveira CS, Justino MC, Rubio P, Gabbay YB, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J). 2007; 83(3):217-24.
4. Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, et al. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine. 2012; 30 Suppl 1:A24-9. doi: 10.1016/j.vaccine.2011.08.124 PMID: 22520132
5. Estes MK, Kapikian AZ. Rotaviruses. In: Knipe D.M., Howley P.M. (Eds.), Fields Virology, 5th ed. Lippincott, Williams & Wilkins, Philadelphia, PA, pp.2007; 1918-1974.
6. Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol Rev. 1989; 53(4):410-49. PMID: 2556635
7. Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011; 156(8):1397-413. doi: 10.1007/s00705-011-1006-z PMID: 21597953
8. Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Banyai K, Rahman M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009; 4(10):1303-16. doi: 10.2217/fmb.09.96 PMID: 19995190
9. Fiore L, Greenberg HB, Mackow ER. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology. 1991; 181(2):553-63. PMID: 1849677
10. Padilla-Noriega L, Dunn SJ, Lopez S, Greenberg HB, Arias CF. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5∗ and VP8∗ of human rotavirus ST3. Virology. 1995; 206(1):148-54. PMID: 7530390
11. Patton JT, Hua J, Mansell EA. Location of intrachain disulfide bonds in the VP5∗ and VP8∗ trypsin cleavage fragments of the rhesus rotavirus spike protein VP4. J Virol. 1993; 67(8):4848-55. PMID: 8392619
12. Arias CF, Isa P, Guerrero CA, Mendez E, Zarate S, Lopez T, et al. Molecular biology of rotavirus cell entry. Arch Med Res. 2002; 33(4):356-61. PMID: 12234525
13. Monnier N, Higo-Moriguchi K, Sun ZY, Prasad BV, Taniguchi K, Dormitzer PR. High-resolution molecular and antigen structure of the VP8∗ core of a sialic acid-independent human rotavirus strain. J Virol. 2006; 80(3):1513-23. PMID: 16415027
14. Isa P, Arias CF, Lopez S. Role of sialic acids in rotavirus infection. Glycoconj J. 2006; 23(1-2):27-37. PMID: 16575520
15. Yolken RH, Willoughby R, Wee SB, Miskuff R, Vonderfecht S. Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J Clin Invest. 1987; 79(1):148-54. PMID: 3025257
16. Ciarlet M, Estes MK. Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol. 1999; 80 (Pt 4):943-8. PMID: 10211964
17. Huang P, Xia M, Tan M, Zhong W, Wei C, Wang L, et al. Spike protein VP8∗ of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol. 2012; 86(9):4833-43. doi: 10.1128/ JVI.05507-11 PMID: 22345472
18. Hu L, Crawford SE, Czako R, Cortes-Penfield NW, Smith DF, Le Pendu J, et al. Cell attachment protein VP8∗ of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature. 2012; 485(7397):256-9. doi: 10.1038/nature10996 PMID: 22504179
19. Ramani S, Cortes-Penfield NW, Hu L, Crawford SE, Czako R, Smith DF, et al. The VP8∗ domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol. 2013; 87(13):7255-64. doi: 10.1128/JVI.03518-12 PMID: 23616650
20. Liu Y, Huang P, Jiang B, Tan M, Morrow AL, Jiang X. Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. PLoS One. 2013; 8(11):e78113. doi: 10.1371/journal.pone.0078113 PMID: 24244290
21. Huang P, Farkas T, Zhong W, Tan M, Thornton S, Morrow AL, et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol. 2005; 79(11):6714-22. PMID: 15890909
22. Van Trang N, Vu HT, Le NT, Huang P, Jiang X, Anh DD. Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol. 2014; 52 (5):1366-74. doi: 10.1128/JCM.02927-13 PMID: 24523471
23. Frenck R, Bernstein DI, Xia M, Huang P, Zhong W, Parker S, et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis. 2012; 206(9):1386-93. doi: 10.1093/ infdis/jis514 PMID: 22927452
24. Bohm R, Fleming FE, Maggioni A, Dang VT, Holloway G, Coulson BS, et al. Revisiting the role of histoblood group antigens in rotavirus host-cell invasion. Nat Commun. 2015; 6:5907. doi: 10.1038/ ncomms6907 PMID: 25556995
25. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, Morrow AL, et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis. 2003; 188(1):19-31. PMID: 12825167
26. Tan M, Jin M, Xie H, Duan Z, Jiang X, Fang Z. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol.2008; 80(7): 1296-301. doi: 10.1002/jmv.21200 PMID: 18461617
27. Dormitzer PR, Sun ZY, Wagner G, Harrison SC. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 2002; 21(5):885-97. PMID: 11867517
28. Le Pendu J. Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol. 2004; 554:135-43. PMID: 15384573
29. Le Pendu J, Ruvoen-Clouet N, Kindberg E, Svensson L. Mendelian resistance to human norovirus infections. Semin Immunol. 2006; 18(6):375-86. PMID: 16973373
30. Esteban LE, Rota RP, Gentsch JR, Jiang B, Esona M, Glass RI, et al. Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: reemergence of G2P[4] and emergence of G9P[8] strains. J Med Virol. 2010; 82(6):1083-93. doi: 10.1002/jmv.21745 PMID: 20419826
31. Imbert-Marcille BM, Barbe L, Dupe M, Le Moullac-Vaidye B, Besse B, Peltier C, et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J Infect Dis. 2014; 209(8):1227-30. doi: 10.1093/infdis/jit655 PMID: 24277741
32. Nordgren J, Sharma S, Bucardo F, Nasir W, Gunaydin G, Ouermi D, et al. Both Lewis and Secretor Status Mediate Susceptibility to Rotavirus Infections in a Rotavirus Genotype-Dependent Manner. Clin Infect Dis. 2014; 59(11):1567-73. doi: 10.1093/cid/ciu633 PMID: 25097083